U.S. stocks before the market opens: Earnings guidance from leading vaccine companies is weaker than expected, dragging down the collective weakness of the sector
U.S. stocks before the market opens: Earnings guidance from leading vaccine companies is weaker than expected, dragging down the collective weakness of the sector